N+1 Singer Reiterates Corporate Rating for Futura Medical plc. (FUM)
Futura Medical plc. (LON:FUM)‘s stock had its “corporate” rating reiterated by analysts at N+1 Singer in a note issued to investors on Thursday.
Shares of Futura Medical plc. (LON:FUM) opened at 64.89999 on Thursday. The firm’s market capitalization is GBX 64.31 million. Futura Medical plc. has a 52 week low of GBX 14.31 and a 52 week high of GBX 95.60. The firm has a 50 day moving average price of GBX 56.33 and a 200-day moving average price of GBX 29.32.
Futura Medical plc. Company Profile
Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin.
Receive News & Ratings for Futura Medical plc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical plc. and related companies with MarketBeat.com's FREE daily email newsletter.